the prestigious Donal Hollywood Award for the best scientific work.
The EMBRACE Collaborative Group is an international study group consisting of centres from Asia, Australia, Europe and the USA under the leadership and coordination of the Department of Radiation Oncology at the Medical University of Vienna in cooperation with partner universities in Denmark and the Netherlands. The aim of the EMBRACE Collaborative Group is to improve the primary radio-oncological treatment of locally advanced cervical cancer.
The results of the EMBRACE II study
‘EMBRACE II - a multicentre prospective interventional cohort study on IGRT-IMRT+cisplatin+MR-IGABT in locally advanced cervix cancer: overall results’ have now been presented for the first time at the award ceremony and show an extraordinary improvement in therapy results both in terms of the chances of cure and the reduction of side effects.
Congratulations!